2332-2036 Screening compound: ethyl 2-(4-bromo-2-fluorobenzamido)-4-methyl-1,3-thiazole-5-carboxylate

2332-2036 Screening compound: ethyl 2-(4-bromo-2-fluorobenzamido)-4-methyl-1,3-thiazole-5-carboxylate
2332-2036 Screening compound: ethyl 2-(4-bromo-2-fluorobenzamido)-4-methyl-1,3-thiazole-5-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound 2332-2036
ethyl 2-(4-bromo-2-fluorobenzamido)-4-methyl-1,3-thiazole-5-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2332-2036

Molecular Formula

C14H12BrFN2O3S (C14 H12 BrFN2 O3 S)

Compound Name

ethyl 2-(4-bromo-2-fluorobenzamido)-4-methyl-1,3-thiazole-5-carboxylate

IUPAC name

ethyl 2-(4-bromo-2-fluorobenzamido)-4-methyl-13-thiazole-5-carboxylate

SMILES

CCOC(c1c(C)nc(NC(c(ccc(Br)c2)c2F)=O)s1)=O

InChI

InChI=1S/C14H12BrFN2O3S/c1-3-21-13(20)11-7(2)17-14(22-11)18-12(19)9-5-4-8(15)6-10(9)16/h4-6H,3H2,1-2H3,(H,17,18,19)

InChI Key

WJSGABZANNRWFX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01538160

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

387.23

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.309

Distribution Coefficient, logD

1.831

Water Solubility, LogSw

-4.31

Polar Surface Area

54.707

Acid Dissociation Constant (pKa)

4.92

Base Dissociation Constant (pKb)

-0.81

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

2332-2036 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

SH2 Library (10483 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Endocrine
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with 2332-2036 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2332-2036?
Check Price and Availability of 2332-2036, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2332-2036 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2332-2036
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2332-2036
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2332-2036 available by request